American Vietnamese Biotech Incorporation reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported revenue was VND 79,120.42 million compared to VND 51,754.01 million a year ago. Net income was VND 33,802.71 million compared to VND 14,186.12 million a year ago. Basic earnings per share from continuing operations was VND 344 compared to VND 180 a year ago. Diluted earnings per share from continuing operations was VND 344 compared to VND 180 a year ago.
For the six months, revenue was VND 126,817.35 million compared to VND 77,521.99 million a year ago. Net income was VND 46,115.24 million compared to VND 13,858.44 million a year ago. Basic earnings per share from continuing operations was VND 479 compared to VND 180 a year ago. Diluted earnings per share from continuing operations was VND 479 compared to VND 180 a year ago.